• Healthcare Triangle Inc. (NASDAQ: HCTI) has entered into a new material agreement to provide cloud-based healthcare solutions.
• Inhibikase Therapeutics (NASDAQ: IKT) shareholders approved an amendment to increase its 2020 Equity Incentive Plan by 3,000,000 shares.
• ImageneBio (NASDAQ: IMA) disclosed the resignation of Senior Vice President of Finance and Operations Robert Lally, effective July 22, 2026.
• The purchase agreement covered an aggregate of 1,470,588 securities, including ADSs or prefunded warrants, each tied to 80,000 ordinary shares.
• The board appointed Kevin G. Sarney as interim chief financial officer under a consulting agreement with Charles River CFO, Inc.
• The company is closing its research facility in Alabama.
• Capricor Therapeutics announced an FDA advisory committee meeting on July 29, 2026, to review its Biologics License Application for Deramiocel.
• The contract is valued at $52.7 million
• Pfizer (PFE) closed at $24.29, up 2.62% on June 26, 2026, drawing attention among large-cap healthcare stocks.
• Thermo Fisher Scientific (TMO) closed at $513.03, up 1.44% on June 26, 2026, drawing attention among large-cap healthcare stocks.